This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopab [2020/07/09 11:19] – [References] rkoebnik | bacteria:t3e:xopab [2025/02/24 11:54] (current) – [Biological function] rkoebnik | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopAB ====== | + | ====== |
- | Author: | + | Author: |
- | Reviewer: Jane Doe | + | |
Class: XopAB\\ | Class: XopAB\\ | ||
Family: XopAB\\ | Family: XopAB\\ | ||
- | Prototype: | + | Prototype: |
- | RefSeq ID:\\ | + | GenBank ID: [[https:// |
+ | RefSeq ID: [[https:// | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 14: | Line 14: | ||
=== How discovered? === | === How discovered? === | ||
+ | XopAB was discovered via genome-wide screening for effector candidates in //X. oryzae// pv. //oryzae// (//Xoo//) strain MAFF 311018 in accordance with three criteria: i) ORF encoding proteins homologous to effectors of //P. syringae// strains and //X. campestris// | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
+ | TT3S-dependent translocation of XopAB has been shown by a calmodulin-dependent adenylate cyclase reporter assay (Furutani //et al.//, 2009). XopR< | ||
=== Regulation === | === Regulation === | ||
Line 34: | Line 36: | ||
===== References ===== | ===== References ===== | ||
- | Furutani A,Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // | + | Furutani A, Takaoka M, Sanada H, Noguchi Y, Oku T, Tsuno K, Ochiai H, Tsuge S (2009). Identification of novel type III secretion effectors in // |
+ | |||
+ | Zhao S, Mo WL, Wu F, Tang W, Tang JL, Szurek B, Verdier V, Koebnik R, Feng JX (2013). Identification of non-TAL effectors in // | ||